HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dual optical recordings for action potentials and calcium handling in induced pluripotent stem cell models of cardiac arrhythmias using genetically encoded fluorescent indicators.

Abstract
Reprogramming of human somatic cells to pluripotency has been used to investigate disease mechanisms and to identify potential therapeutics. However, the methods used for reprogramming, in vitro differentiation, and phenotyping are still complicated, expensive, and time-consuming. To address the limitations, we first optimized a protocol for reprogramming of human fibroblasts and keratinocytes into pluripotency using single lipofection and the episomal vectors in a 24-well plate format. This method allowed us to generate multiple lines of integration-free and feeder-free induced pluripotent stem cells (iPSCs) from seven patients with cardiac diseases and three controls. Second, we differentiated human iPSCs derived from patients with Timothy syndrome into cardiomyocytes using a monolayer differentiation method. We found that Timothy syndrome cardiomyocytes showed slower, irregular contractions and abnormal calcium handling compared with the controls. The results are consistent with previous reports using a retroviral method for reprogramming and an embryoid body-based method for cardiac differentiation. Third, we developed an efficient approach for recording the action potentials and calcium transients simultaneously in control and patient cardiomyocytes using genetically encoded fluorescent indicators, ArcLight and R-GECO1. The dual optical recordings enabled us to observe prolonged action potentials and abnormal calcium handling in Timothy syndrome cardiomyocytes. We confirmed that roscovitine rescued the phenotypes in Timothy syndrome cardiomyocytes and that these findings were consistent with previous studies using conventional electrophysiological recordings and calcium imaging with dyes. The approaches using our optimized methods and dual optical recordings will improve iPSC applicability for disease modeling to investigate mechanisms underlying cardiac arrhythmias and to test potential therapeutics.
AuthorsLouJin Song, Daniel W Awari, Elizabeth Y Han, Eugenia Uche-Anya, Seon-Hye E Park, Yoko A Yabe, Wendy K Chung, Masayuki Yazawa
JournalStem cells translational medicine (Stem Cells Transl Med) Vol. 4 Issue 5 Pg. 468-75 (May 2015) ISSN: 2157-6564 [Print] England
PMID25769651 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Copyright©AlphaMed Press.
Chemical References
  • Arclight fusion protein
  • Luminescent Proteins
  • Recombinant Fusion Proteins
  • Calcium
Topics
  • Action Potentials (genetics)
  • Arrhythmias, Cardiac (pathology)
  • Autistic Disorder
  • Calcium (metabolism)
  • Cell Differentiation (genetics)
  • Cellular Reprogramming (genetics)
  • Humans
  • Induced Pluripotent Stem Cells (cytology, metabolism)
  • Keratinocytes (cytology)
  • Long QT Syndrome (pathology)
  • Luminescent Proteins (chemistry)
  • Myocytes, Cardiac (cytology)
  • Phenotype
  • Recombinant Fusion Proteins (chemistry)
  • Syndactyly (pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: